Page results
-
We work together closely to support and improve the health of people with type 1 and type 2 diabetes via education, training, research and through other services that we provide. Our team works in close collaboration with ophthalmologists, vascular surgeons, endocrine surgeons, obstetricians and paediatricians.
-
Four women have successfully had combined surgery at UCLH in which they gave birth by caesarean section and at the same time had surgery to reduce their risk of ovarian cancer.
-
UCLH is a designated specialist centre for the treatment of head and neck cancer for people in north and east London and west Essex.
-
Dr Edwin Jabbari is a consultant neurologist working at the National Hospital for Neurology and Neurosurgery with clinical and research expertise in movement disorders.
-
This information is for patients who have fibroids. It contains information about what fibroids are, how they can affect you and what treatments are available.
-
Our endocrinology service provides care for patients with a broad range of endocrine conditions in outpatient clinics, as well as after inpatient endocrine emergencies. It also provides a consultation service for inpatients with endocrine conditions.
-
UCLH has over 15 years’ experience as a leading centre for the treatment of mesh complications and mesh removal.
-
Our general medicine services aim to diagnose and advise patients with a range of medical problems.
-
The Haemophagocytic Lymphohistiocytosis (HLH) Service was established at UCLH to offer high-quality care for people suspected of having HLH.
-
Cerebral palsy (CP) is a permanent disorder affecting movement in different parts of the body often accompanied by disturbances of sensation, cognition, communication, perception, behaviour and musculoskeletal problems.
File results
-
FOI/2022/0174 - Clinical systems for bed management, diagnostic reporting, discharge letters, and integration platform systems
-
FOI/2022/0177 - Assessment and treatment unit for mental health and learning disabilities
-
FOI/2022/0186 - Gender neutral toilets at the Trust
-
FOI/2022/0187 - Intra-operative cell salvage procedures
-
FOI/2022/0189 - Drug treatments for Revolade, Nplate, Doptelet, and Tavlesse
-
FOI/2022/0190 - Spend on private healthcare providers for staff
-
FOI/2022/0192 - Drug treatment for Melanoma patients
-
FOI/2022/0193 - Drug treatment for breast cancer
-
FOI/2022/0194 - Drug treatment for lung cancer
-
FOI/2022/0199 - Trust postal service and patient communication